Australia markets close in 43 minutes

Trinity Biotech plc (TRIB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.3800-0.0100 (-0.72%)
At close: 04:00PM EDT

Trinity Biotech plc

IDA Business Park
Bray
Ireland
353 1 276 9800
https://www.trinitybiotech.com

Sector(s):Β Healthcare
Industry:Β Diagnostics & Research
Full-time employees:Β 477

Key executives

NameTitlePayExercisedYear born
Mr. Ronan O'CaoimhChief Exec. Officer643kN/A1956
Mr. John GillardCFO, Company Sec. & Exec. Director593kN/A1981
Dr. James Walsh Ph.D.Exec. Director20kN/A1958
Mr. Simon DunneChief Accounting OfficerN/AN/A1974
Ms. Eibhlin KellyChief Information OfficerN/AN/A1984
Mr. Fernando DeviaExec. VP of SalesN/AN/A1963
Mr. Sanjiv SuriSr. VP of Global Sales & GM of North AmericaN/AN/A1959
Amounts are as of 31 December 2021, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Trinity Biotech plc acquires, develops, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas, Africa, Asia, and Europe. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detect infectious diseases, such as lyme disease; sexually transmitted diseases consisting syphilis and herpes; SARS-CoV-2; and epstein barr, measles, mumps, toxoplasmosis, cytomegalovirus, rubella, varicella and other viral pathogens, as well as products for the in-vitro diagnostic testing for haemoglobin A1c used in the monitoring and diagnosis of diabetes, and identifying those who are at a risk of developing diabetes. It also develops, manufactures, and sells products in the immunofluorescence assay, enzyme-linked immunosorbent, western blot, and line immunoassay formats; and provides reagent products, such as ACE, bile acids, lactate, oxalate, and glucose-6-phosphate dehydrogenase for diagnosis of liver and kidney diseases, as well as haemolytic anaemia. In addition, the company sells raw materials to the life sciences industry and research institutes. It serves public health authorities, non-governmental organisations, and clinical and reference laboratories through its direct sales force, as well as through a network of independent distributors and strategic partners. Trinity Biotech plc was incorporated in 1992 and is headquartered in Bray, Ireland.

Corporate governance

Trinity Biotech plc’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.